CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score

References

• Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2019 Available from: http://goldcopd.org/. Accessed 122, 2020.
   Google Scholar
• MakrisD, MoschandreasJ, DamianakiA, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101:1305–1312. doi:10.1016/j.rmed.2006.10.01217112715
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, SeemungalTA, BhowmikA, WedzichaJA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. doi:10.1136/thorax.57.10.84712324669
   PubMed Web of Science ®Google Scholar
• ByngD, LutterJI, WackerME, et al. Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET. Int J Chron Obstruct Pulmon Dis. 2019;14:1423–1439. doi:10.2147/COPD.S20189931308648
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJ, Martinez-GarciaMA, Roman SanchezP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• BafadhelM, McKennaS, TerryS, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662–671. doi:10.1164/rccm.201104-0597OC21680942
   PubMed Web of Science ®Google Scholar
• ZhouA, ZhouZ, ZhaoY, ChenP. The recent advances of phenotypes in acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1009–1018. doi:10.2147/COPD28392685
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• NishimuraK, IzumiT, TsukinoM, OgaT. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–1440. doi:10.1378/chest.121.5.143412006425
   PubMed Web of Science ®Google Scholar
• VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• AlmagroP, SorianoJB, CabreraFJ, et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145:972–980. doi:10.1378/chest.13-132824077342
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• PuhanMA, Garcia-AymerichJ, FreyM, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374:704–711. doi:10.1016/S0140-6736(09)61301-519716962
   PubMed Web of Science ®Google Scholar
• van ManenJG, BindelsPJ, DekkerFW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57:412–416. doi:10.1136/thorax.57.5.41211978917
   PubMed Web of Science ®Google Scholar
• Di MarcoF, VergaM, ReggenteM, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767–1774. doi:10.1016/j.rmed.2006.01.02616531031
   PubMed Web of Science ®Google Scholar
• QuintJK, Baghai-RavaryR, DonaldsonGC, WedzichaJA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32:53–60. doi:10.1183/09031936.0012010718321938
   PubMed Web of Science ®Google Scholar
• ZungWW. A Self-Rating Depression Scale. Arch Gen Psychiatry. 1965;12:63–70. doi:10.1001/archpsyc.1965.0172031006500814221692
   PubMed Web of Science ®Google Scholar
• ZungWW. From art to science. The diagnosis and treatment of depression. Arch Gen Psychiatry. 1973;29:328–337. doi:10.1001/archpsyc.1973.042000300260044724142
   PubMed Web of Science ®Google Scholar
• QuanH, LiB, CourisCM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682. doi:10.1093/aje/kwq43321330339
   PubMed Web of Science ®Google Scholar
• ZhouA, ZhouZ, PengY, et al. The role of CAT in evaluating the response to treatment of patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2849–2858. doi:10.2147/COPD.S17508530237709
   PubMed Web of Science ®Google Scholar
• ZhouZ, ZhouA, ZhaoY, DuanJ, ChenP. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1675–1682. doi:10.2147/COPD29872285
   PubMed Web of Science ®Google Scholar
• Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi:10.1164/ajrccm.166.1.at110212091180
   PubMed Web of Science ®Google Scholar
• Espantoso-RomeroM, Roman RodriguezM, Duarte-PerezA, et al. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort). BMC Pulm Med. 2016;16:143. doi:10.1186/s12890-016-0305-227835945
   PubMed Web of Science ®Google Scholar
• MikkelsenRL, MiddelboeT, PisingerC, StageKB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58:65–70. doi:10.1080/0803948031000082414985157
   PubMed Web of Science ®Google Scholar
• YohannesAM, AlexopoulosGS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23:345–349. doi:10.1183/09059180.0000781325176970
   PubMedGoogle Scholar
• ZhangMW, HoRC, CheungMW, FuE, MakA. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33:217–223. doi:10.1016/j.genhosppsych.2011.03.00921601717
   PubMed Web of Science ®Google Scholar
• MatteDL, PizzichiniMM, HoepersAT, et al. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154–161. doi:10.1016/j.rmed.2016.06.00627492526
   PubMed Web of Science ®Google Scholar
• HananiaNA, MullerovaH, LocantoreNW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183:604–611. doi:10.1164/rccm.201003-0472OC20889909
   PubMed Web of Science ®Google Scholar
• NorwoodR. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12:113–117. doi:10.1097/01.mcp.0000208450.50231.c616456380
   PubMed Web of Science ®Google Scholar
• SchneiderC, JickSS, BothnerU, MeierCR. COPD and the risk of depression. Chest. 2010;137:341–347. doi:10.1378/chest.09-061419801582
   PubMed Web of Science ®Google Scholar
• ZiderAD, WangX, BuhrRG, et al. Reduced COPD exacerbation risk correlates with improved FEV1: a meta-regression analysis. Chest. 2017;152:494–501. doi:10.1016/j.chest.2017.04.17428483609
   PubMed Web of Science ®Google Scholar
• Garcia-GutierrezS, QuintanaJM, UnzurrunzagaA, et al. Predictors of change in dyspnea level in acute exacerbations of COPD. COPD. 2016;13:303–311. doi:10.3109/15412555.2015.107878426667827
   PubMedGoogle Scholar
• GuerraB, GaveikaiteV, BianchiC, PuhanMA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26:160061.28096287
   PubMed Web of Science ®Google Scholar
• AlmagroP, Martinez-CamblorP, MiravitllesM, et al. External validation and recalculation of the CODEX index in COPD patients. A 3CIAplus Cohort study. COPD. 2019;16:8–17. doi:10.1080/15412555.2018.148444030870059
   PubMedGoogle Scholar
• MarinJM, CarrizoSJ, CasanovaC, et al. Prediction of risk of COPD exacerbations by the BODE index. Respir Med. 2009;103:373–378. doi:10.1016/j.rmed.2008.10.00419013781
   PubMed Web of Science ®Google Scholar
• ChenCZ, OuCY, YuCH, et al. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2015;63:244–250. doi:10.1111/jgs.1325825641518
   PubMed Web of Science ®Google Scholar
• JonesRC, PriceD, ChavannesNH, et al. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets. NPJ Prim Care Respir Med. 2016;26:16010. doi:10.1038/npjpcrm.2016.1027053297
   PubMed Web of Science ®Google Scholar
• ZhouA, LuoL, LiuN, et al. Prospective development of practical screening strategies for diagnosis of asthma-COPD overlap. Respirology. Epub 2019 Nov 27.
   Web of Science ®Google Scholar